| Market Cap | ₹1,433Cr |
| ROE | 12.98% |
| P/E Ratio(TTM) | 32.16 |
| EPS(TTM) | 52.40 |
| P/B Ratio | 4.24 |
| Dividend Yield | 0.42% |
| Industry P/E | 33.51 |
| Book Value | 397.22 |
| Debt to Equity | 0.63 |
| Face Value | 10 |
| Parent Organisation | Hester Biosciences |
| Managing Director | Mr. Rajiv Gandhi |
| NSE Symbol | HESTERBIO |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Torrent Pharmaceuticals | NA (0.00%) | 59.99 | ||
| Ajanta Pharma | NA (0.00%) | 31.57 | ||
| Gland Pharma | NA (0.00%) | 37.31 | ||
| Eris Lifesciences | NA (0.00%) | 47.75 |